These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15082236)

  • 1. Incorporation of mammalian metabolism into mutagenicity testing.
    Malling HV
    Mutat Res; 2004 May; 566(3):183-9. PubMed ID: 15082236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 4. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic and carcinogenic potential of menadione.
    Cojocel C; Novotny L; Vachalkova A
    Neoplasma; 2006; 53(4):316-23. PubMed ID: 16830059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of the science of mutagenesis from a personal perspective.
    Malling HV
    Environ Mol Mutagen; 2004; 44(5):372-86. PubMed ID: 15529325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxins.
    Liu X; Kramer JA; Swaffield JC; Hu Y; Chai G; Wilson AG
    Mutat Res; 2008 May; 653(1-2):63-9. PubMed ID: 18485802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for analysis of the mutagenicity of indirect mutagens/carcinogens in eukaryotic cells.
    Madle S; Obe G
    Hum Genet; 1980; 56(1):7-20. PubMed ID: 7009387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The induction of mutation and differentiation in mammalian cells by chemicals which initiate or promote tumor formation.
    Huberman E
    Dev Toxicol Environ Sci; 1980; 8():121-32. PubMed ID: 7030700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy for the risk assessment of human genotoxic metabolites.
    Dobo KL; Obach RS; Luffer-Atlas D; Bercu JP
    Chem Res Toxicol; 2009 Feb; 22(2):348-56. PubMed ID: 19170655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term assays to predict carcinogenicity. Metabolic activation.
    Venitt S; Bartsch H; Becking G; Fuchs RP; Hofnung M; Malaveille C; Matsushima T; Mendelsohn ML; Pegg AE; Roberfroid M
    IARC Sci Publ; 1986; (83):439-55. PubMed ID: 3305349
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection of cytochrome P450 cDNAs into mammalian cells used in mutation and transformation assays.
    Langenbach R; Crespi C; Davies R; Rudo K; Smith P; Hansen S; Ross J; Siegfried J; Nesnow S
    Prog Clin Biol Res; 1990; 340D():239-48. PubMed ID: 2371297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of covalent binding of reactive metabolites and examples of activation of bis-electrophiles by conjugation.
    Guengerich FP
    Arch Biochem Biophys; 2005 Jan; 433(2):369-78. PubMed ID: 15581593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
    Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
    Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
    Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the structural requirements for mutagenicity by incorporating molecular flexibility and metabolic activation of chemicals I: TA100 model.
    Mekenyan O; Dimitrov S; Serafimova R; Thompson E; Kotov S; Dimitrova N; Walker JD
    Chem Res Toxicol; 2004 Jun; 17(6):753-66. PubMed ID: 15206896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.